BCX9250
/ BioCryst
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 08, 2022
"$BCRX FDA Grants Fast Track Designation for BioCryst’s ALK-2 Inhibitor, BCX9250 https://t.co/M6IY6ZPnJe"
(@stock_titan)
Fast track designation • FDA event
1 to 1
Of
1
Go to page
1